相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Prognostic Impact of PD-1 on Tumor-Infiltrating Lymphocytes in 433 Resected Esophageal Cancers
Daichi Nomoto et al.
ANNALS OF THORACIC SURGERY (2022)
CD226: a potent driver of antitumor immunity that needs to be maintained
Jiacheng Bi
CELLULAR & MOLECULAR IMMUNOLOGY (2022)
Cancer statistics, 2022
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
Mechanistic convergence of the TIGIT and PD-1 inhibitory pathways necessitates co-blockade to optimize anti-tumor CD8+ T cell responses
Karl L. Banta et al.
IMMUNITY (2022)
TIGIT-CD226-PVR axis: advancing immune checkpoint blockade for cancer immunotherapy
Eugene Y. Chiang et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)
Delineating the transcriptional landscape and clonal diversity of virus-specific CD4+ T cells during chronic viral infection
Ryan Zander et al.
ELIFE (2022)
Pan-cancer landscape of T-cell exhaustion heterogeneity within the tumor microenvironment revealed a progressive roadmap of hierarchical dysfunction associated with prognosis and therapeutic efficacy
Zicheng Zhang et al.
EBIOMEDICINE (2022)
Single-cell Profiles and Prognostic Impact of Tumor-Infiltrating Lymphocytes Coexpressing CD39, CD103, and PD-1 in Ovarian Cancer
Celine M. Laumont et al.
CLINICAL CANCER RESEARCH (2021)
Integrated analysis of multimodal single-cell data
Yuhan Hao et al.
CELL (2021)
The T cell receptor repertoire of tumor infiltrating T cells is predictive and prognostic for cancer survival
Sara Valpione et al.
NATURE COMMUNICATIONS (2021)
A single-cell atlas of liver metastases of colorectal cancer reveals reprogramming of the tumor microenvironment in response to preoperative chemotherapy
Li-Heng Che et al.
CELL DISCOVERY (2021)
Strategies to tackle RAS-mutated metastatic colorectal cancer
G. Patelli et al.
ESMO OPEN (2021)
BCL9 regulates CD226 and CD96 checkpoints in CD8+ T cells to improve PD-1 response in cancer
Mei Feng et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
PD-1/PD-L1 expression and tumor-infiltrating lymphocytes are prognostically favorable in advanced high-grade serous ovarian carcinoma
Laura Martin de la Fuente et al.
VIRCHOWS ARCHIV (2020)
CD226hiCD8+ T Cells Are a Prerequisite for Anti-TIGIT Immunotherapy
Hyung-seung Jin et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Eomes-Dependent Loss of the Co-activating Receptor CD226 Restrains CD8(+) T Cell Anti-tumor Functions and Limits the Efficacy of Cancer Immunotherapy
Marianne Weulersse et al.
IMMUNITY (2020)
CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8+ T Cells
Matthias Braun et al.
IMMUNITY (2020)
Comprehensive evaluation of transcriptome-based cell-type quantification methods for immuno-oncology
Gregor Sturm et al.
BIOINFORMATICS (2019)
DNAM-1 and the TIGIT/PVRIG/TACTILE Axis: Novel Immune Checkpoints for Natural Killer Cell-Based Cancer Immunotherapy
Beatriz Sanchez-Correa et al.
CANCERS (2019)
CD155 expression in human breast cancer: Clinical significance and relevance to natural killer cell infiltration
Hana Triki et al.
LIFE SCIENCES (2019)
Fast, sensitive and accurate integration of single-cell data with Harmony
Ilya Korsunsky et al.
NATURE METHODS (2019)
Targeting PVR (CD155) and its receptors in anti-tumor therapy
Paola Kucan Brlic et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2019)
Proliferating Transitory T Cells with an Effector-like Transcriptional Signature Emerge from PD-1+ Stem-like CD8+ T Cells during Chronic Infection
William H. Hudson et al.
IMMUNITY (2019)
CD8+ T cells expressing both PD-1 and TIGIT but not CD226 are dysfunctional in acute myeloid leukemia (AML) patients
Mengjie Wang et al.
CLINICAL IMMUNOLOGY (2018)
Immune Responses in the Liver
Paul Kubes et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 36 (2018)
Surgical Treatment of Metastatic Colorectal Cancer
Jeffery Chakedis et al.
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2018)
NK Cell Education in Tumor Immune Surveillance: DNAM-1/KIR Receptor Ratios as Predictive Biomarkers for Solid Tumor Outcome
Concepcion F. Guillamon et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Evolution of Metastases in Space and Time under Immune Selection
Mihaela Angelova et al.
CELL (2018)
Combination cancer immunotherapy targeting PD-1 and GITR can rescue CD8(+) T cell dysfunction and maintain memory phenotype
Bei Wang et al.
SCIENCE IMMUNOLOGY (2018)
Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancer
Claudio Isella et al.
NATURE COMMUNICATIONS (2017)
The presence of PD-1 positive tumor infiltrating lymphocytes in triple negative breast cancers is associated with a favorable outcome of disease
Gero Brockhoff et al.
Oncotarget (2017)
PD1-positive tumor-infiltrating lymphocytes are associated with poor clinical outcome after pulmonary metastasectomy for colorectal cancer
Dagmar Kollmann et al.
ONCOIMMUNOLOGY (2017)
QuPath: Open source software for digital pathology image analysis
Peter Bankhead et al.
SCIENTIFIC REPORTS (2017)
TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data
Antonio Colaprico et al.
NUCLEIC ACIDS RESEARCH (2016)
Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression
Etienne Becht et al.
GENOME BIOLOGY (2016)
TIGIT and PD-1 impair tumor antigen-specific CD8+ T cells in melanoma patients
Joe-Marc Chauvin et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Increased CD226 Expression on CD8+ T Cells Is Associated with Upregulated Cytokine Production and Endothelial Cell Injury in Patients with Systemic Sclerosis
Masahiro Ayano et al.
JOURNAL OF IMMUNOLOGY (2015)
Blocking oncogenic RAS enhances tumour cell surface MHC class I expression but does not alter susceptibility to cytotoxic lymphocytes
Jehan El-Jawhari et al.
MOLECULAR IMMUNOLOGY (2014)
Localization and Density of Immune Cells in the Invasive Margin of Human Colorectal Cancer Liver Metastases Are Prognostic for Response to Chemotherapy
Niels Halama et al.
CANCER RESEARCH (2011)
Intratumoral T cell infiltration, MHC class I and STAT1 as biomarkers of good prognosis in colorectal cancer
Jonathan A. D. Simpson et al.
GUT (2010)
T Cell Infiltrate Predicts Long-Term Survival Following Resection of Colorectal Cancer Liver Metastases
Steven C. Katz et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
DNAM-1 promotes activation of cytotoxic lymphocytes by nonprofessional antigen-presenting cells and tumors
Susan Gilfillan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
Jerom Galon et al.
SCIENCE (2006)
Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients
ME Dudley et al.
JOURNAL OF IMMUNOTHERAPY (2003)